CD4 and myelodysplastic syndrome: In order to identify potential mechanisms of Th17 cells in the pathogenesis of MDS, we initially assessed the percentage of both Th17 cells/CD3+CD4+ cells and Th17 cells/CD3+ cells (T lymphocytes) in PB and BM of patients with different risks of MDS (Figures 1(b)–1(e)).